News Channels

19 Mar 2019 NeuroVive Enrolls First Subject in its KL1333 Phase Ia/b Clinical Study
19 Mar 2019 Alkahest Doses First Subject in Phase 2 Clinical Trial of Lead Candidate in Patients with Severe Alzheimer's Disease
19 Mar 2019 Cytovation Initiates Clinical Development Programme With CyPep-1, a First-in-class Lytic Agent for Tumor Immunotherapy
19 Mar 2019 Théa and OliX Announce Collaboration to Develop RNAi Therapies for the Treatment of AMD
19 Mar 2019 Innovent Announces First Patient Dosed in Phase I Clinical Trial of Anti-CD47 Monoclonal Antibody in the U.S.
19 Mar 2019 Allergy Therapeutics announces top-line Phase III results from its B301 clinical trial
19 Mar 2019 Dermira Announces Positive Topline Results from Phase 2b Study of Lebrikizumab in Patients with Atopic Dermatitis
19 Mar 2019 Zenith Epigenetics Announces U.S. FDA Clearance of Investigational New Drug Application for ZEN-3694 in TNBC Program
19 Mar 2019 BioAegis Therapeutics Completes Enrollment in its Phase 1b/2a Dose-Ranging Safety Study of Recombinant Plasma Gelsolin for Community-Acquired Pneumonia
19 Mar 2019 Amphera Recruits First Patients to Pivotal Phase II/III study of MesoPher to Treat Pleural Mesothelioma
19 Mar 2019 IMV and Centre de Recherche du CHU de Québec-Université Laval Collaboration Awarded a CQDM Grant to Develop First-in-Class Dual Target T Cell Therapy in Bladder Cancer Based on IMV’s DPX Technology
19 Mar 2019 Ono Pharmaceutical and twoXAR Announce Drug Discovery Research Collaboration
19 Mar 2019 Boehringer Ingelheim announces FDA and EMA regulatory submission for nintedanib in systemic sclerosis associated ILD
19 Mar 2019 Nicox Initiates Phase 2 Trial of NCX 4251 in Blepharitis
19 Mar 2019 AUGUSTUS Demonstrates Favorable Safety Results of Eliquis® Versus Vitamin K Antagonists in Non-Valvular Atrial Fibrillation Patients with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention
19 Mar 2019 Aerie Pharmaceuticals Initiates Phase 2 Clinical Trial of AR-1105 (Dexamethasone Intravitreal Implant) in Patients with Macular Edema Associated with Retinal Vein Occlusion
19 Mar 2019 China National Biotec Group (CNBG) and ImmunoBiology Ltd Enter Licensing Agreement to Co-Develop Next Generation Vaccine against Pneumococcal Disease in Greater China
19 Mar 2019 Aerpio Pharmaceuticals Announces Results From TIME-2b Study of AKB-9778 in Diabetic Retinopathy
19 Mar 2019 U.S. FDA Accepts BLA Filing of Aimmune Therapeutics’ AR101 for Peanut Allergy
19 Mar 2019 Puma Biotechnology Presents Interim Results from the Phase II SUMMIT Trial of Neratinib for HER2 (ERBB2) Mutant, Metastatic Cervical Cancer at the Society of Gynecologic Oncology (SGO) 2019 Annual Meeting

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up